nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Carmustine—brain cancer	0.34	0.771	CbGbCtD
Anagrelide—CYP1A2—Etoposide—brain cancer	0.101	0.229	CbGbCtD
Anagrelide—Bronchitis—Temozolomide—brain cancer	0.00132	0.00236	CcSEcCtD
Anagrelide—Dry mouth—Procarbazine—brain cancer	0.00132	0.00236	CcSEcCtD
Anagrelide—Pancytopenia—Temozolomide—brain cancer	0.0013	0.00233	CcSEcCtD
Anagrelide—Cardiac failure—Etoposide—brain cancer	0.0013	0.00233	CcSEcCtD
Anagrelide—Confusional state—Procarbazine—brain cancer	0.0013	0.00233	CcSEcCtD
Anagrelide—Vomiting—Lomustine—brain cancer	0.00129	0.00231	CcSEcCtD
Anagrelide—Oedema—Procarbazine—brain cancer	0.00129	0.00231	CcSEcCtD
Anagrelide—Dysuria—Temozolomide—brain cancer	0.00128	0.0023	CcSEcCtD
Anagrelide—Infection—Procarbazine—brain cancer	0.00128	0.0023	CcSEcCtD
Anagrelide—Pneumonia—Carmustine—brain cancer	0.00127	0.00228	CcSEcCtD
Anagrelide—Shock—Procarbazine—brain cancer	0.00127	0.00227	CcSEcCtD
Anagrelide—Pollakiuria—Temozolomide—brain cancer	0.00127	0.00227	CcSEcCtD
Anagrelide—Erectile dysfunction—Temozolomide—brain cancer	0.00127	0.00226	CcSEcCtD
Anagrelide—Thrombocytopenia—Procarbazine—brain cancer	0.00126	0.00226	CcSEcCtD
Anagrelide—Depression—Carmustine—brain cancer	0.00126	0.00226	CcSEcCtD
Anagrelide—Chills—Hydroxyurea—brain cancer	0.00126	0.00226	CcSEcCtD
Anagrelide—Tachycardia—Procarbazine—brain cancer	0.00126	0.00225	CcSEcCtD
Anagrelide—Photosensitivity reaction—Temozolomide—brain cancer	0.00125	0.00224	CcSEcCtD
Anagrelide—Weight increased—Temozolomide—brain cancer	0.00125	0.00224	CcSEcCtD
Anagrelide—Hyperhidrosis—Procarbazine—brain cancer	0.00125	0.00223	CcSEcCtD
Anagrelide—Renal failure—Carmustine—brain cancer	0.00125	0.00223	CcSEcCtD
Anagrelide—Alopecia—Hydroxyurea—brain cancer	0.00124	0.00222	CcSEcCtD
Anagrelide—Weight decreased—Temozolomide—brain cancer	0.00124	0.00222	CcSEcCtD
Anagrelide—Urinary tract infection—Carmustine—brain cancer	0.00123	0.0022	CcSEcCtD
Anagrelide—Pneumonia—Temozolomide—brain cancer	0.00123	0.0022	CcSEcCtD
Anagrelide—Anorexia—Procarbazine—brain cancer	0.00123	0.0022	CcSEcCtD
Anagrelide—Depression—Temozolomide—brain cancer	0.00122	0.00218	CcSEcCtD
Anagrelide—Nausea—Lomustine—brain cancer	0.00121	0.00216	CcSEcCtD
Anagrelide—Hypotension—Procarbazine—brain cancer	0.00121	0.00216	CcSEcCtD
Anagrelide—Urinary tract infection—Temozolomide—brain cancer	0.00119	0.00213	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00118	0.0021	CcSEcCtD
Anagrelide—Insomnia—Procarbazine—brain cancer	0.00117	0.00209	CcSEcCtD
Anagrelide—Paraesthesia—Procarbazine—brain cancer	0.00116	0.00207	CcSEcCtD
Anagrelide—Hepatobiliary disease—Temozolomide—brain cancer	0.00116	0.00207	CcSEcCtD
Anagrelide—Sinusitis—Temozolomide—brain cancer	0.00115	0.00205	CcSEcCtD
Anagrelide—Somnolence—Procarbazine—brain cancer	0.00115	0.00205	CcSEcCtD
Anagrelide—Haemoglobin—Carmustine—brain cancer	0.00114	0.00204	CcSEcCtD
Anagrelide—Haemorrhage—Carmustine—brain cancer	0.00114	0.00203	CcSEcCtD
Anagrelide—Ill-defined disorder—Hydroxyurea—brain cancer	0.00114	0.00203	CcSEcCtD
Anagrelide—Anaemia—Hydroxyurea—brain cancer	0.00113	0.00202	CcSEcCtD
Anagrelide—Hypoaesthesia—Carmustine—brain cancer	0.00113	0.00202	CcSEcCtD
Anagrelide—Decreased appetite—Procarbazine—brain cancer	0.00112	0.00201	CcSEcCtD
Anagrelide—Oedema peripheral—Carmustine—brain cancer	0.00112	0.002	CcSEcCtD
Anagrelide—Connective tissue disorder—Carmustine—brain cancer	0.00112	0.002	CcSEcCtD
Anagrelide—Fatigue—Procarbazine—brain cancer	0.00111	0.00199	CcSEcCtD
Anagrelide—Haemoglobin—Temozolomide—brain cancer	0.00111	0.00198	CcSEcCtD
Anagrelide—Malaise—Hydroxyurea—brain cancer	0.0011	0.00198	CcSEcCtD
Anagrelide—Pain—Procarbazine—brain cancer	0.0011	0.00198	CcSEcCtD
Anagrelide—Constipation—Procarbazine—brain cancer	0.0011	0.00198	CcSEcCtD
Anagrelide—Haemorrhage—Temozolomide—brain cancer	0.0011	0.00197	CcSEcCtD
Anagrelide—Hepatitis—Temozolomide—brain cancer	0.0011	0.00197	CcSEcCtD
Anagrelide—Dysphagia—Etoposide—brain cancer	0.0011	0.00197	CcSEcCtD
Anagrelide—Visual impairment—Carmustine—brain cancer	0.0011	0.00196	CcSEcCtD
Anagrelide—Hypoaesthesia—Temozolomide—brain cancer	0.00109	0.00196	CcSEcCtD
Anagrelide—Pharyngitis—Temozolomide—brain cancer	0.00109	0.00195	CcSEcCtD
Anagrelide—Urinary tract disorder—Temozolomide—brain cancer	0.00109	0.00194	CcSEcCtD
Anagrelide—Oedema peripheral—Temozolomide—brain cancer	0.00108	0.00194	CcSEcCtD
Anagrelide—Connective tissue disorder—Temozolomide—brain cancer	0.00108	0.00193	CcSEcCtD
Anagrelide—Urethral disorder—Temozolomide—brain cancer	0.00108	0.00193	CcSEcCtD
Anagrelide—Feeling abnormal—Procarbazine—brain cancer	0.00106	0.0019	CcSEcCtD
Anagrelide—Eye disorder—Carmustine—brain cancer	0.00106	0.0019	CcSEcCtD
Anagrelide—Convulsion—Hydroxyurea—brain cancer	0.00106	0.0019	CcSEcCtD
Anagrelide—Visual impairment—Temozolomide—brain cancer	0.00106	0.00189	CcSEcCtD
Anagrelide—Gastrointestinal pain—Procarbazine—brain cancer	0.00106	0.00189	CcSEcCtD
Anagrelide—Pancytopenia—Etoposide—brain cancer	0.00104	0.00187	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00104	0.00185	CcSEcCtD
Anagrelide—Discomfort—Hydroxyurea—brain cancer	0.00103	0.00184	CcSEcCtD
Anagrelide—Eye disorder—Temozolomide—brain cancer	0.00103	0.00184	CcSEcCtD
Anagrelide—Urticaria—Procarbazine—brain cancer	0.00103	0.00184	CcSEcCtD
Anagrelide—Tinnitus—Temozolomide—brain cancer	0.00103	0.00183	CcSEcCtD
Anagrelide—Abdominal pain—Procarbazine—brain cancer	0.00102	0.00183	CcSEcCtD
Anagrelide—Body temperature increased—Procarbazine—brain cancer	0.00102	0.00183	CcSEcCtD
Anagrelide—Cardiac disorder—Temozolomide—brain cancer	0.00102	0.00182	CcSEcCtD
Anagrelide—Arrhythmia—Carmustine—brain cancer	0.00102	0.00182	CcSEcCtD
Anagrelide—Alopecia—Carmustine—brain cancer	0.00101	0.0018	CcSEcCtD
Anagrelide—Oedema—Hydroxyurea—brain cancer	0.001	0.00179	CcSEcCtD
Anagrelide—Infection—Hydroxyurea—brain cancer	0.000993	0.00178	CcSEcCtD
Anagrelide—Mediastinal disorder—Temozolomide—brain cancer	0.000991	0.00177	CcSEcCtD
Anagrelide—Malnutrition—Carmustine—brain cancer	0.00099	0.00177	CcSEcCtD
Anagrelide—Chills—Temozolomide—brain cancer	0.000987	0.00176	CcSEcCtD
Anagrelide—Pneumonia—Etoposide—brain cancer	0.000986	0.00176	CcSEcCtD
Anagrelide—Nervous system disorder—Hydroxyurea—brain cancer	0.000981	0.00175	CcSEcCtD
Anagrelide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000979	0.00175	CcSEcCtD
Anagrelide—Alopecia—Temozolomide—brain cancer	0.000972	0.00174	CcSEcCtD
Anagrelide—Skin disorder—Hydroxyurea—brain cancer	0.000971	0.00174	CcSEcCtD
Anagrelide—Acute coronary syndrome—Etoposide—brain cancer	0.000966	0.00173	CcSEcCtD
Anagrelide—Renal failure—Etoposide—brain cancer	0.000963	0.00172	CcSEcCtD
Anagrelide—Myocardial infarction—Etoposide—brain cancer	0.000961	0.00172	CcSEcCtD
Anagrelide—Back pain—Carmustine—brain cancer	0.000958	0.00171	CcSEcCtD
Anagrelide—Malnutrition—Temozolomide—brain cancer	0.000957	0.00171	CcSEcCtD
Anagrelide—Anorexia—Hydroxyurea—brain cancer	0.000953	0.0017	CcSEcCtD
Anagrelide—Vision blurred—Carmustine—brain cancer	0.000933	0.00167	CcSEcCtD
Anagrelide—Asthenia—Procarbazine—brain cancer	0.000927	0.00166	CcSEcCtD
Anagrelide—Hepatobiliary disease—Etoposide—brain cancer	0.000927	0.00166	CcSEcCtD
Anagrelide—Back pain—Temozolomide—brain cancer	0.000926	0.00166	CcSEcCtD
Anagrelide—Anaemia—Carmustine—brain cancer	0.000915	0.00164	CcSEcCtD
Anagrelide—Pruritus—Procarbazine—brain cancer	0.000914	0.00163	CcSEcCtD
Anagrelide—Vision blurred—Temozolomide—brain cancer	0.000902	0.00161	CcSEcCtD
Anagrelide—Dyspnoea—Hydroxyurea—brain cancer	0.000891	0.00159	CcSEcCtD
Anagrelide—Somnolence—Hydroxyurea—brain cancer	0.000889	0.00159	CcSEcCtD
Anagrelide—Ill-defined disorder—Temozolomide—brain cancer	0.000888	0.00159	CcSEcCtD
Anagrelide—Anaemia—Temozolomide—brain cancer	0.000885	0.00158	CcSEcCtD
Anagrelide—Diarrhoea—Procarbazine—brain cancer	0.000884	0.00158	CcSEcCtD
Anagrelide—Dyspepsia—Hydroxyurea—brain cancer	0.00088	0.00157	CcSEcCtD
Anagrelide—Hypoaesthesia—Etoposide—brain cancer	0.000875	0.00157	CcSEcCtD
Anagrelide—Decreased appetite—Hydroxyurea—brain cancer	0.000869	0.00155	CcSEcCtD
Anagrelide—Urinary tract disorder—Etoposide—brain cancer	0.000869	0.00155	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000863	0.00154	CcSEcCtD
Anagrelide—Malaise—Temozolomide—brain cancer	0.000863	0.00154	CcSEcCtD
Anagrelide—Urethral disorder—Etoposide—brain cancer	0.000862	0.00154	CcSEcCtD
Anagrelide—Fatigue—Hydroxyurea—brain cancer	0.000862	0.00154	CcSEcCtD
Anagrelide—Convulsion—Carmustine—brain cancer	0.000858	0.00153	CcSEcCtD
Anagrelide—Hypertension—Carmustine—brain cancer	0.000855	0.00153	CcSEcCtD
Anagrelide—Pain—Hydroxyurea—brain cancer	0.000855	0.00153	CcSEcCtD
Anagrelide—Constipation—Hydroxyurea—brain cancer	0.000855	0.00153	CcSEcCtD
Anagrelide—Dizziness—Procarbazine—brain cancer	0.000854	0.00153	CcSEcCtD
Anagrelide—Palpitations—Temozolomide—brain cancer	0.000846	0.00151	CcSEcCtD
Anagrelide—Myalgia—Carmustine—brain cancer	0.000843	0.00151	CcSEcCtD
Anagrelide—Chest pain—Carmustine—brain cancer	0.000843	0.00151	CcSEcCtD
Anagrelide—Cough—Temozolomide—brain cancer	0.000835	0.00149	CcSEcCtD
Anagrelide—Convulsion—Temozolomide—brain cancer	0.000829	0.00148	CcSEcCtD
Anagrelide—Hypertension—Temozolomide—brain cancer	0.000826	0.00148	CcSEcCtD
Anagrelide—Feeling abnormal—Hydroxyurea—brain cancer	0.000824	0.00147	CcSEcCtD
Anagrelide—Eye disorder—Etoposide—brain cancer	0.000822	0.00147	CcSEcCtD
Anagrelide—Vomiting—Procarbazine—brain cancer	0.000821	0.00147	CcSEcCtD
Anagrelide—Cardiac disorder—Etoposide—brain cancer	0.000817	0.00146	CcSEcCtD
Anagrelide—Confusional state—Carmustine—brain cancer	0.000815	0.00146	CcSEcCtD
Anagrelide—Myalgia—Temozolomide—brain cancer	0.000815	0.00146	CcSEcCtD
Anagrelide—Arthralgia—Temozolomide—brain cancer	0.000815	0.00146	CcSEcCtD
Anagrelide—Rash—Procarbazine—brain cancer	0.000815	0.00146	CcSEcCtD
Anagrelide—Dermatitis—Procarbazine—brain cancer	0.000814	0.00146	CcSEcCtD
Anagrelide—Headache—Procarbazine—brain cancer	0.000809	0.00145	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000809	0.00145	CcSEcCtD
Anagrelide—Oedema—Carmustine—brain cancer	0.000808	0.00145	CcSEcCtD
Anagrelide—Discomfort—Temozolomide—brain cancer	0.000805	0.00144	CcSEcCtD
Anagrelide—Infection—Carmustine—brain cancer	0.000803	0.00144	CcSEcCtD
Anagrelide—Dry mouth—Temozolomide—brain cancer	0.000797	0.00142	CcSEcCtD
Anagrelide—Mediastinal disorder—Etoposide—brain cancer	0.000793	0.00142	CcSEcCtD
Anagrelide—Thrombocytopenia—Carmustine—brain cancer	0.000791	0.00142	CcSEcCtD
Anagrelide—Body temperature increased—Hydroxyurea—brain cancer	0.00079	0.00141	CcSEcCtD
Anagrelide—Chills—Etoposide—brain cancer	0.000789	0.00141	CcSEcCtD
Anagrelide—Tachycardia—Carmustine—brain cancer	0.000789	0.00141	CcSEcCtD
Anagrelide—Confusional state—Temozolomide—brain cancer	0.000788	0.00141	CcSEcCtD
Anagrelide—Oedema—Temozolomide—brain cancer	0.000781	0.0014	CcSEcCtD
Anagrelide—Alopecia—Etoposide—brain cancer	0.000777	0.00139	CcSEcCtD
Anagrelide—Infection—Temozolomide—brain cancer	0.000776	0.00139	CcSEcCtD
Anagrelide—Anorexia—Carmustine—brain cancer	0.00077	0.00138	CcSEcCtD
Anagrelide—Nausea—Procarbazine—brain cancer	0.000767	0.00137	CcSEcCtD
Anagrelide—Nervous system disorder—Temozolomide—brain cancer	0.000766	0.00137	CcSEcCtD
Anagrelide—Thrombocytopenia—Temozolomide—brain cancer	0.000765	0.00137	CcSEcCtD
Anagrelide—Skin disorder—Temozolomide—brain cancer	0.000759	0.00136	CcSEcCtD
Anagrelide—Hypotension—Carmustine—brain cancer	0.000755	0.00135	CcSEcCtD
Anagrelide—Hyperhidrosis—Temozolomide—brain cancer	0.000755	0.00135	CcSEcCtD
Anagrelide—Anorexia—Temozolomide—brain cancer	0.000745	0.00133	CcSEcCtD
Anagrelide—Back pain—Etoposide—brain cancer	0.000741	0.00132	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000736	0.00132	CcSEcCtD
Anagrelide—Muscle spasms—Etoposide—brain cancer	0.000736	0.00132	CcSEcCtD
Anagrelide—Insomnia—Carmustine—brain cancer	0.000731	0.00131	CcSEcCtD
Anagrelide—Paraesthesia—Carmustine—brain cancer	0.000726	0.0013	CcSEcCtD
Anagrelide—Dyspnoea—Carmustine—brain cancer	0.000721	0.00129	CcSEcCtD
Anagrelide—Somnolence—Carmustine—brain cancer	0.000719	0.00128	CcSEcCtD
Anagrelide—Asthenia—Hydroxyurea—brain cancer	0.000717	0.00128	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000712	0.00127	CcSEcCtD
Anagrelide—Ill-defined disorder—Etoposide—brain cancer	0.000711	0.00127	CcSEcCtD
Anagrelide—Anaemia—Etoposide—brain cancer	0.000708	0.00127	CcSEcCtD
Anagrelide—Insomnia—Temozolomide—brain cancer	0.000706	0.00126	CcSEcCtD
Anagrelide—Decreased appetite—Carmustine—brain cancer	0.000703	0.00126	CcSEcCtD
Anagrelide—Paraesthesia—Temozolomide—brain cancer	0.000701	0.00125	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Carmustine—brain cancer	0.000698	0.00125	CcSEcCtD
Anagrelide—Dyspnoea—Temozolomide—brain cancer	0.000696	0.00125	CcSEcCtD
Anagrelide—Somnolence—Temozolomide—brain cancer	0.000694	0.00124	CcSEcCtD
Anagrelide—Constipation—Carmustine—brain cancer	0.000691	0.00124	CcSEcCtD
Anagrelide—Pain—Carmustine—brain cancer	0.000691	0.00124	CcSEcCtD
Anagrelide—Malaise—Etoposide—brain cancer	0.000691	0.00123	CcSEcCtD
Anagrelide—Dyspepsia—Temozolomide—brain cancer	0.000688	0.00123	CcSEcCtD
Anagrelide—Diarrhoea—Hydroxyurea—brain cancer	0.000684	0.00122	CcSEcCtD
Anagrelide—Decreased appetite—Temozolomide—brain cancer	0.000679	0.00121	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000674	0.00121	CcSEcCtD
Anagrelide—Fatigue—Temozolomide—brain cancer	0.000673	0.0012	CcSEcCtD
Anagrelide—Loss of consciousness—Etoposide—brain cancer	0.000673	0.0012	CcSEcCtD
Anagrelide—Cough—Etoposide—brain cancer	0.000668	0.0012	CcSEcCtD
Anagrelide—Pain—Temozolomide—brain cancer	0.000668	0.00119	CcSEcCtD
Anagrelide—Constipation—Temozolomide—brain cancer	0.000668	0.00119	CcSEcCtD
Anagrelide—Feeling abnormal—Carmustine—brain cancer	0.000666	0.00119	CcSEcCtD
Anagrelide—Convulsion—Etoposide—brain cancer	0.000664	0.00119	CcSEcCtD
Anagrelide—Hypertension—Etoposide—brain cancer	0.000661	0.00118	CcSEcCtD
Anagrelide—Dizziness—Hydroxyurea—brain cancer	0.000661	0.00118	CcSEcCtD
Anagrelide—Gastrointestinal pain—Carmustine—brain cancer	0.000661	0.00118	CcSEcCtD
Anagrelide—Chest pain—Etoposide—brain cancer	0.000652	0.00117	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000648	0.00116	CcSEcCtD
Anagrelide—Discomfort—Etoposide—brain cancer	0.000644	0.00115	CcSEcCtD
Anagrelide—Feeling abnormal—Temozolomide—brain cancer	0.000644	0.00115	CcSEcCtD
Anagrelide—Abdominal pain—Carmustine—brain cancer	0.000639	0.00114	CcSEcCtD
Anagrelide—Body temperature increased—Carmustine—brain cancer	0.000639	0.00114	CcSEcCtD
Anagrelide—Gastrointestinal pain—Temozolomide—brain cancer	0.000639	0.00114	CcSEcCtD
Anagrelide—Vomiting—Hydroxyurea—brain cancer	0.000636	0.00114	CcSEcCtD
Anagrelide—Rash—Hydroxyurea—brain cancer	0.00063	0.00113	CcSEcCtD
Anagrelide—Confusional state—Etoposide—brain cancer	0.00063	0.00113	CcSEcCtD
Anagrelide—Dermatitis—Hydroxyurea—brain cancer	0.00063	0.00113	CcSEcCtD
Anagrelide—Headache—Hydroxyurea—brain cancer	0.000626	0.00112	CcSEcCtD
Anagrelide—Infection—Etoposide—brain cancer	0.000621	0.00111	CcSEcCtD
Anagrelide—Urticaria—Temozolomide—brain cancer	0.000621	0.00111	CcSEcCtD
Anagrelide—Abdominal pain—Temozolomide—brain cancer	0.000617	0.0011	CcSEcCtD
Anagrelide—Body temperature increased—Temozolomide—brain cancer	0.000617	0.0011	CcSEcCtD
Anagrelide—Thrombocytopenia—Etoposide—brain cancer	0.000612	0.00109	CcSEcCtD
Anagrelide—Tachycardia—Etoposide—brain cancer	0.00061	0.00109	CcSEcCtD
Anagrelide—Skin disorder—Etoposide—brain cancer	0.000607	0.00109	CcSEcCtD
Anagrelide—Hyperhidrosis—Etoposide—brain cancer	0.000604	0.00108	CcSEcCtD
Anagrelide—Anorexia—Etoposide—brain cancer	0.000596	0.00107	CcSEcCtD
Anagrelide—Nausea—Hydroxyurea—brain cancer	0.000594	0.00106	CcSEcCtD
Anagrelide—Hypotension—Etoposide—brain cancer	0.000584	0.00104	CcSEcCtD
Anagrelide—Asthenia—Carmustine—brain cancer	0.00058	0.00104	CcSEcCtD
Anagrelide—Paraesthesia—Etoposide—brain cancer	0.000561	0.001	CcSEcCtD
Anagrelide—Asthenia—Temozolomide—brain cancer	0.00056	0.001	CcSEcCtD
Anagrelide—Dyspnoea—Etoposide—brain cancer	0.000557	0.000996	CcSEcCtD
Anagrelide—Somnolence—Etoposide—brain cancer	0.000556	0.000994	CcSEcCtD
Anagrelide—Diarrhoea—Carmustine—brain cancer	0.000553	0.000989	CcSEcCtD
Anagrelide—Pruritus—Temozolomide—brain cancer	0.000553	0.000988	CcSEcCtD
Anagrelide—Decreased appetite—Etoposide—brain cancer	0.000543	0.000972	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Etoposide—brain cancer	0.00054	0.000965	CcSEcCtD
Anagrelide—Fatigue—Etoposide—brain cancer	0.000539	0.000964	CcSEcCtD
Anagrelide—Dizziness—Carmustine—brain cancer	0.000535	0.000956	CcSEcCtD
Anagrelide—Pain—Etoposide—brain cancer	0.000535	0.000956	CcSEcCtD
Anagrelide—Constipation—Etoposide—brain cancer	0.000535	0.000956	CcSEcCtD
Anagrelide—Diarrhoea—Temozolomide—brain cancer	0.000534	0.000956	CcSEcCtD
Anagrelide—Dizziness—Temozolomide—brain cancer	0.000517	0.000924	CcSEcCtD
Anagrelide—Feeling abnormal—Etoposide—brain cancer	0.000515	0.000921	CcSEcCtD
Anagrelide—Vomiting—Carmustine—brain cancer	0.000514	0.000919	CcSEcCtD
Anagrelide—Gastrointestinal pain—Etoposide—brain cancer	0.000511	0.000914	CcSEcCtD
Anagrelide—Rash—Carmustine—brain cancer	0.00051	0.000911	CcSEcCtD
Anagrelide—Dermatitis—Carmustine—brain cancer	0.000509	0.00091	CcSEcCtD
Anagrelide—Headache—Carmustine—brain cancer	0.000506	0.000905	CcSEcCtD
Anagrelide—Vomiting—Temozolomide—brain cancer	0.000497	0.000888	CcSEcCtD
Anagrelide—Urticaria—Etoposide—brain cancer	0.000497	0.000888	CcSEcCtD
Anagrelide—Abdominal pain—Etoposide—brain cancer	0.000494	0.000884	CcSEcCtD
Anagrelide—Body temperature increased—Etoposide—brain cancer	0.000494	0.000884	CcSEcCtD
Anagrelide—Rash—Temozolomide—brain cancer	0.000493	0.000881	CcSEcCtD
Anagrelide—Dermatitis—Temozolomide—brain cancer	0.000492	0.00088	CcSEcCtD
Anagrelide—Headache—Temozolomide—brain cancer	0.000489	0.000875	CcSEcCtD
Anagrelide—Nausea—Carmustine—brain cancer	0.00048	0.000858	CcSEcCtD
Anagrelide—Nausea—Temozolomide—brain cancer	0.000464	0.00083	CcSEcCtD
Anagrelide—Asthenia—Etoposide—brain cancer	0.000448	0.000802	CcSEcCtD
Anagrelide—Pruritus—Etoposide—brain cancer	0.000442	0.000791	CcSEcCtD
Anagrelide—Diarrhoea—Etoposide—brain cancer	0.000428	0.000765	CcSEcCtD
Anagrelide—Dizziness—Etoposide—brain cancer	0.000413	0.000739	CcSEcCtD
Anagrelide—Vomiting—Etoposide—brain cancer	0.000397	0.000711	CcSEcCtD
Anagrelide—Rash—Etoposide—brain cancer	0.000394	0.000705	CcSEcCtD
Anagrelide—Dermatitis—Etoposide—brain cancer	0.000394	0.000704	CcSEcCtD
Anagrelide—Headache—Etoposide—brain cancer	0.000392	0.0007	CcSEcCtD
Anagrelide—Nausea—Etoposide—brain cancer	0.000371	0.000664	CcSEcCtD
